Year,Value,Series
2018,97,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)
2019,98,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)
2018,92,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)
2019,92,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)
2018,97,Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)
2019,98,Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)
